Experience with ceftazidime-avibactam treatment in a tertiary care center in Saudi Arabia
Introduction: Carbapenem-resistant organisms have become major healthcare-associated pathogens and are responsible for significant morbidity and mortality worldwide. Cases and managements: This case-series describes our experience with ceftazidime-avibactam in the treatment of six cases with carbape...
Salvato in:
| Autori principali: | , , , , , , , |
|---|---|
| Natura: | Libro |
| Pubblicazione: |
Elsevier,
2018-11-01T00:00:00Z.
|
| Soggetti: | |
| Accesso online: | Connect to this object online. |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| Riassunto: | Introduction: Carbapenem-resistant organisms have become major healthcare-associated pathogens and are responsible for significant morbidity and mortality worldwide. Cases and managements: This case-series describes our experience with ceftazidime-avibactam in the treatment of six cases with carbapenem-resistant organisms in King Abdulaziz Medical City in Riyadh, Saudi Arabia. After trying various combinations of antibiotic therapies without improvement, cases were treated with ceftazidime-avibactam. Outcomes: Five of the six achieved complete cure, both clinically and microbiologically. Keywords: MDR-infections, Ceftazidime-avibactam, Saudi Arabia |
|---|---|
| Descrizione del documento: | 1876-0341 10.1016/j.jiph.2018.04.013 |